The expression of H3K9ace in myocardium decreased in the MI group and the CEA group but increased significantly after EA treatment (P<0.01), which corresponded with the changes in VEGF (Fig.6B, 6D). The gene discussed is VEGFA; the disease is myocardial infarction.